POTASSIUM CITRATE
NDC 72865-193, Potassium Citrate, tablet, extended release, from XLCare Pharmaceuticals, Inc..
- Product NDC
- 72865-193
- Status
- Listed
- Labeler
- XLCare Pharmaceuticals, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214420
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72865-193 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POTASSIUM CITRATE15 meq/1
Pharmacologic classes
Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72865-193-01 | 72865019301 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-193-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/360a1012-4bdb-473a-8f1f-4550d3b51343
Use it
Look up 72865-193 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72865-193 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72865-193. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.